USA wins gold in sinemet olympics

Gold: USA. American company based in New Jersey declared world-wide shortage; but USA not included in “world-wide”. No shortage in USA.
Silver: Canada and U.K. tied: minor shortages.
Bronze: Spain, Switzerland, Sweden – substantial shortages.
Disqualified: Kenya, Australia. Man in Nairobi reports no sinemet available; he had thought it was only Kenya, not elsewhere. Austrilia also said to be cut off entirely.
Is it because Americans pay more for drugs, and have more competition? World Health Org. reports that in Uganda, brand-name drugs cost 13.6 times more than something called “the international price reference; generics cost 2.6 times more. But no indication of who collects that extra money.
http://www.who.int/features/factfile...en/index3.html
Unable to find info about the other 135 countries where Merck sells product.
WHO lists levodopa as one of the 340 essential medicines that all member countries must have in stock. Scction 9 of the 16th revised list of essential medicines, approved in March 2009. Biperiden and carbidopa also on the list.
Multi-national drug companies deal with mere nations one at a time; Parkies have no international representation.